Skip to content
OpenCapital
Get started

LONA LONA EBITDA

EBITDA at other companies

Arvinas logo
ArvinasARVN
-$63.1M-188%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
-$57.87M-66.5%
Aura Biosciences, Inc. logo
Aura Biosciences, Inc.AURA
-$34.59M-20.3%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
-$30.39M+28.0%
Erasca, Inc. logo
Erasca, Inc.ERAS
-$187.19M-438%
Eli Lilly logo
Eli LillyLLY
——

Other financials

Income statement

See full
Operating income-$17.2M-80.5%
Net income-$32.9M-260%
EPS (diluted)-$1.73+26.1%

Balance sheet

See full
Cash & equivalents$32.8M+24.3%
Total debt$691.0K-38.2%
Total equity$49.3M+32.1%
Total assets$71.6M+64.5%

Cash flow

See full
Operating cash flow-$20.9M-42.5%
CapEx$28.0K-15.2%
Free cash flow-$26.0M+1.1%

Valuation

See full
Market cap$86.33M+223%
Enterprise value$54.18M—

Returns & leverage

See full
Return on equity-298.8%-726pp
Debt / equity0×0.0×
Current ratio10.4×+3.1×

Where this comes from

Calculated from LONA’s reported figures.

−$17.2Mebit+
$231.0KDepreciation Depletion & Amortization
=-$16.98M

The official record: LONA’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about LONA's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LONA's EBITDA?
LONA (LONA) reported EBITDA of -$16.98M in Q1 2026.
How has LONA's EBITDA changed year-over-year?
LONA's EBITDA decreased by 82.8% year-over-year, from -$9.29M to -$16.98M.
What is the long-term trend for LONA's EBITDA?
Over 4 years (2021 to 2025), LONA's EBITDA has grown at a 12.4% compound annual growth rate (CAGR), from -$63.54M to -$101.38M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.